Ellipsis Research Group - Brooklyn - 7th Street

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Obesity1 trial
• Osteoarthritis1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials

Running trials

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Jorge Serje (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06045221· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

  NCT05971940· Phase 3· Eli Lilly and Company· Source